Tremeau Pharmaceuticals, Inc.
Pharmaceutical company · Cambridge, Massachusetts, United States
Tremeau Pharmaceuticals, Inc. is a pharmaceutical company headquartered in Cambridge, Massachusetts, United States. Its earliest recorded incorporation is in 2016. It has reported private securities offerings to the US SEC, most recently $5.2 million sold in a notice filed in 2018.
Tremeau Pharmaceuticals at a glance
What does Tremeau Pharmaceuticals do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $5.2 million sold (2018).
Frequently asked questions about Tremeau Pharmaceuticals
Where is Tremeau Pharmaceuticals headquartered?
Tremeau Pharmaceuticals, Inc. is headquartered in Cambridge, Massachusetts, United States.
What does Tremeau Pharmaceuticals do?
Tremeau Pharmaceuticals, Inc. is a pharmaceutical company.
When was Tremeau Pharmaceuticals founded?
The earliest incorporation on record for Tremeau Pharmaceuticals, Inc. is in 2016, according to public company registers.
Similar companies
- Spero Therapeutics, Inc.Cambridge, Massachusetts, United States
- Sarepta Therapeutics, Inc.Cambridge, Massachusetts, United States
- Alnylam Pharmaceuticals, Inc.Cambridge, Massachusetts, United States
- Visterra, Inc.Cambridge, Massachusetts, United States
- Seres Therapeutics, Inc.Cambridge, Massachusetts, United States
- Merrimack Pharmaceuticals IncCambridge, Massachusetts, United States
- QurAlis CorpCambridge, Massachusetts, United States
- Apnimed, Inc.Cambridge, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences